Lataa...
Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited blistering diseases that affects ∼ 500,000 people worldwide. Clinically, individuals with EB have fragile skin and are susceptible to blistering following minimal trauma, with mucous membrane and other organ...
Tallennettuna:
| Julkaisussa: | Intractable Rare Dis Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5359356/ https://ncbi.nlm.nih.gov/pubmed/28357176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2017.01005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|